Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Smotect Azaadi is a clinically validated Ayurvedic herbal formulation developed by Smotec Pharmaceuticals for smoking cessation and the management of nicotine dependence. It is a nicotine-free product that utilizes a blend of standardized herbal extracts, including *Mucuna pruriens*, *Withania somnifera*, and *Bacopa monnieri*, to address both the physical and psychological aspects of tobacco addiction. The formulation works by naturally enhancing dopamine levels to reduce cravings, while its adaptogenic properties help mitigate withdrawal symptoms such as anxiety, irritability, and stress. Smotect Azaadi is marketed as a safe, non-addictive alternative to traditional Nicotine Replacement Therapy (NRT) and has undergone clinical trials to demonstrate its efficacy in improving quit rates and supporting lung health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Smotect Azaadi.